Developing a new technology for isolating and analyzing exosomes
Capillary-channeled polymers fibers and films - A platform technology for exosome isolation and analytics
This study is working on a new way to better collect tiny particles called exosomes from different samples, which could help doctors understand diseases and create new treatments, making it easier for patients to get the care they need.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Clemson University NIH-funded |
| Lab location | 1 site (Clemson, United States) |
| Project ID | NIH-11129479 on NIH RePORTER |
What this research studies
This research focuses on creating a novel platform technology using capillary-channeled polymer fibers and films to efficiently isolate exosomes, which are tiny vesicles involved in cell communication. By improving the methods for capturing these exosomes from various biological samples, the research aims to enhance their use in disease diagnostics and as potential drug delivery systems. Patients may benefit from advancements in understanding diseases and developing new therapeutic strategies based on exosome analysis.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with conditions that could benefit from enhanced diagnostic methods or novel therapeutic approaches involving exosomes.
Not a fit: Patients who do not have conditions related to exosome biology or who are not seeking advanced diagnostic or therapeutic options may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved diagnostic tools and therapies for various diseases through better utilization of exosomes.
How similar studies have performed: Other research has shown promise in utilizing exosomes for diagnostics and therapeutics, indicating that this approach has potential based on previous findings.
Where this research is happening
Clemson, United States
- Clemson University — Clemson, United States (Active)
Researchers
- Principal investigator: Marcus, Richard Kenneth — Clemson University
- Study coordinator: Marcus, Richard Kenneth
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.